ScholarIQanswers from OpenAlex

Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI

PaperCitations, authors & open-access status

Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI have?

ScholarIQcitation count

Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI has 67 citations in the OpenAlex counts ScholarIQ stores.

When was Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI published?

ScholarIQyear

Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI has 2020 year in the ScholarIQ index.

What is the open-access status of Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI?

ScholarIQoa status

Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI has closed oa status in the ScholarIQ index.

What is the DOI of Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI?

ScholarIQdoi

The DOI for Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI is on the source record.

What is the PMID of Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI?

ScholarIQpmid

The PMID for Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI is on the source record.

What is the OpenAlex record for Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI?

ScholarIQopenalex

The OpenAlex for Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial